Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Engineering pH-dependent antigen binding activity into anti-HIV antibodies with improved pharmacokinetics

Engineering pH-dependent antigen binding activity into anti-HIV antibodies with improved pharmacokinetics

US Patent 12012451 · Granted Jun 18, 2024

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Antibodies that target HIV gp120 and methods of use2025
Multi-specific antigen binding molecules targeting HIV and methods of use2025
Methods of identifying HIV patients sensitive to therapy with GP120 V3 glycan-di2024
Bispecific HIV-1-neutralizing antibodies2024
Human immunodeficiency virus neutralizing antibodies2023
Multispecific antibodies that target HIV GP120 and CD32023
Antibodies that target HIV GP120 and methods of use2021
Human immunodeficiency virus neutralizing antibodies2021
Tri-specific antibodies for HIV therapy2020
Bispecific HIV-1-neutralizing antibodies2019
Human immunodeficiency virus neutralizing antibodies2019
Bispecific HIV-1 neutralizing antibodies2018